CA2741799A1 - Protective mask with breathable filtering face seal - Google Patents
Protective mask with breathable filtering face seal Download PDFInfo
- Publication number
- CA2741799A1 CA2741799A1 CA2741799A CA2741799A CA2741799A1 CA 2741799 A1 CA2741799 A1 CA 2741799A1 CA 2741799 A CA2741799 A CA 2741799A CA 2741799 A CA2741799 A CA 2741799A CA 2741799 A1 CA2741799 A1 CA 2741799A1
- Authority
- CA
- Canada
- Prior art keywords
- mask
- filter body
- compressible gasket
- scrim
- gasket
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000001914 filtration Methods 0.000 title claims abstract description 73
- 230000001681 protective effect Effects 0.000 title claims abstract description 7
- 239000011347 resin Substances 0.000 claims abstract description 63
- 229920005989 resin Polymers 0.000 claims abstract description 63
- 239000000463 material Substances 0.000 claims abstract description 36
- 230000003115 biocidal effect Effects 0.000 claims abstract description 12
- -1 polypropylene Polymers 0.000 claims description 35
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 32
- 239000013543 active substance Substances 0.000 claims description 32
- 239000004743 Polypropylene Substances 0.000 claims description 30
- 229920001155 polypropylene Polymers 0.000 claims description 30
- 239000000835 fiber Substances 0.000 claims description 26
- 239000011780 sodium chloride Substances 0.000 claims description 16
- 244000005700 microbiome Species 0.000 claims description 10
- 230000035515 penetration Effects 0.000 claims description 10
- 239000011159 matrix material Substances 0.000 claims description 8
- 239000000356 contaminant Substances 0.000 claims description 7
- 239000000758 substrate Substances 0.000 claims description 7
- 229920002821 Modacrylic Polymers 0.000 claims description 5
- 238000011109 contamination Methods 0.000 claims description 3
- 239000004750 melt-blown nonwoven Substances 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 5
- 239000003795 chemical substances by application Substances 0.000 description 28
- 229910001868 water Inorganic materials 0.000 description 25
- 239000000843 powder Substances 0.000 description 21
- 239000002245 particle Substances 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 230000000845 anti-microbial effect Effects 0.000 description 15
- 238000000034 method Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000000853 adhesive Substances 0.000 description 9
- 230000001070 adhesive effect Effects 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 8
- 238000010998 test method Methods 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- 239000004599 antimicrobial Substances 0.000 description 5
- 239000000645 desinfectant Substances 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 239000011630 iodine Substances 0.000 description 5
- 229920000126 latex Polymers 0.000 description 5
- 238000011100 viral filtration Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 150000002739 metals Chemical class 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 229910052709 silver Inorganic materials 0.000 description 4
- 239000004332 silver Substances 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 108700012359 toxins Proteins 0.000 description 4
- 229960003500 triclosan Drugs 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000709744 Enterobacterio phage MS2 Species 0.000 description 3
- 241000194032 Enterococcus faecalis Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000588747 Klebsiella pneumoniae Species 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 206010041925 Staphylococcal infections Diseases 0.000 description 3
- 229940032049 enterococcus faecalis Drugs 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 208000037797 influenza A Diseases 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 230000005923 long-lasting effect Effects 0.000 description 3
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 3
- XEBWQGVWTUSTLN-UHFFFAOYSA-M phenylmercury acetate Chemical compound CC(=O)O[Hg]C1=CC=CC=C1 XEBWQGVWTUSTLN-UHFFFAOYSA-M 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 241000233866 Fungi Species 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000002599 biostatic effect Effects 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- KDTZBYPBMTXCSO-UHFFFAOYSA-N 2-phenoxyphenol Chemical compound OC1=CC=CC=C1OC1=CC=CC=C1 KDTZBYPBMTXCSO-UHFFFAOYSA-N 0.000 description 1
- 229930091051 Arenine Natural products 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 229920005601 base polymer Polymers 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 229920005594 polymer fiber Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Landscapes
- Respiratory Apparatuses And Protective Means (AREA)
Abstract
The invention is directed to a protective mask that has high filtration efficiency, yet is easy to breathe through and is comfortable to wear. The mask includes a thin filter body layer configured to cover the mouth and nose of a user when the mask is worn and a thicker compressible gasket positioned along a periphery of the mask. The gasket comprises a high loft, porous dielectric filtering material that forms a breathable closure about the user's face without forming an airtight seal, such that the user can draw breathable air from the sides, top, and bottom of the mask. The mask preferably includes a outer scrim coated with biocidal iodinated resin to provide surface antibacterial properties.
Description
Agent Ref: 69308/00006 1 Protective Mask with Breathable Filtering Face Seal
2 FIELD OF THE INVENTION
3 This invention relates generally to protective masks. More particularly, in certain
4 embodiments, the invention relates to N95 respirators.
BACKGROUND OF INVENTION
6 There are a variety of different types of facemasks that are commercially available (as 7 used herein, the terms "mask" and "facemask" are used interchangeably and include, without 8 limitation, face masks, respirators, face shields, surgical masks, filter masks, mouth masks, and 9 gas masks). These facemasks serve various functions which include providing protection from splashes and filtering air-borne contaminants, including pathogens. Facemasks differ 11 substantially in their filtering capacity and their comfort level. Loose fitting facemasks generally 12 provide a significant level of comfort at the expense of filtration ability. As such, these 13 facemasks provide little more than splash protection. On the other hand, facemasks that are 14 designed to have excellent filtering properties do not provide a sufficient level of comfort.
Accordingly, developing a comfortable facemask that has desirable filtration capacity is a 16 long-standing goal. One of the problems facing present filtering facemasks is providing a proper 17 fit to a wide variety of individual wearers such than an airtight seal is maintained about the 18 periphery of the mask, forcing all inhaled air to travel through the filter. There are a wide range 19 of face shapes, and it is therefore difficult to manufacture a facemask that maintains a 100%
airtight seal between the skin and the mask for a wide variety of individuals Various different 21 technological means have been tried, such as using adhesive seals, flat and wide seals, and 22 resilient material seals. The function of these seals is to prevent air from penetrating the top, 23 bottom and sides of the mask (i.e., the periphery of the mask). Ideally, all of the breathable air 24 passes through the front of the mask and is filtered, while the periphery of the mask is sealed against the face with a substantially "airtight" seal to prevent breathable air flow there through.
26 However, in these masks, the pressure differential generated at the periphery of the 27 mask actually forces air into gaps which form from time to time between the seal and skin, thus 28 bypassing the air filter material. Thus, a sufficient quantity of unfiltered air still gets through the 29 top, bottom and sides of the mask. Consider a user wearing an airtight-sealing facemask - the user would experience the pressure differential as a suction holding the mask against the user's 22115965.1 1 Agent Ref: 69308/00006 1 face with an airtight seal formed around the edge of the mask. If the mask does not properly fit 2 a given user, the airtight seal may fail to engage and render the user unprotected, since most of 3 the air breathed in will be unfiltered air from the gap in the seal. If the mask fits properly and 4 initially creates an airtight seal, the seal may become compromised by any gap that forms between the user's face and the edge of the mask due to movement of the user's face while 6 wearing the mask. In this case, the pressure differential between the exterior and interior of the 7 mask may actually promote entry of unfiltered air into the mask any time the seal is broken.
8 This unfiltered air is then breathed in by the user, thereby defeating the purpose of the 9 facemask.
Moreover, the airtight seal at the periphery of the mask renders the mask uncomfortable 11 and makes communication difficult. Some wearers complain of a "suction"
that causes 12 temporary marks on the face. Also, masks which form an airtight seal against the face may 13 cause breathing air to be unpleasantly warm or humid. The majority of advances in the 14 facemask industry have involved attempts to improve the filtering properties of facemasks by creating an improved airtight seal. However, these facemasks all, to some degree, suffer from 16 the same drawbacks as described above. Wearer discomfort may result in noncompliance with 17 respirator use rules of a particular establishment.
18 Given the shortcomings of the prior art, there exists a need for a new facemask that has 19 outstanding filtering capacity and provides a high level of comfort to the wearer. The mask should be able to filter and/or deactivate a large array of microbes and other dangerous 21 contaminants.
23 The present invention overcomes the aforementioned problems of the prior art. The 24 invention is directed to a protective mask that has high filtration efficiency, yet is easy to breathe through and is comfortable to wear. The mask includes a thin filter body layer configured to 26 cover the mouth and nose of a user when the mask is worn and a thicker compressible gasket 27 positioned along a periphery of the mask. The gasket comprises a high loft, porous dielectric 28 filtering material that forms a breathable seal/closure about the user's face without forming an 29 airtight seal, such that the user can draw breathable air from the sides, top, and bottom of the mask. The mask preferably includes an outer scrim coated with biocidal iodinated resin to 31 provide surface antibacterial properties.
22115965.1 2 Agent Ref: 69308/00006 1 There is no airtight or even semi-airtight seal formed around the periphery of the mask.
2 The user simply breathes in air that freely passes through the high loft breathable dielectric 3 filtering material that forms the compressible gasket around the periphery of the mask and 4 conforms to the user's face. The user also can breathe air directly through the center of the mask (interior to the gasket filter material), which is also filtered. Because there is no airtight 6 seal, there is no excessive pressure difference between the exterior and interior of the mask.
7 The high loft material conforms to the face of the user, and can accommodate a wide variety of 8 face shapes, as well as the movement of faces during use.
9 The compressible gasket is comprised of a three-dimensional breathable material which is designed to abut the face of a wearer. The compressible gasket does not create an airtight 11 junction but rather is designed to allow breathable air to pass through while providing a sufficient 12 level of comfort to the wearer. The air passing through the compressible gasket is effectively 13 filtered.
14 In one aspect, the invention is directed to a protective mask for filtering and/or deactivating contaminants in air, the mask including: a filter body comprising a nonwoven 16 filtering substrate, the filter body configured to cover the mouth and nose of a user when the 17 mask is worn; and a compressible gasket comprising a high loft, porous dielectric filtering 18 material, the gasket positioned along a periphery of the mask, the gasket configured to abut the 19 user's face when the mask is worn, thereby forming a breathable closure without forming an airtight or even a substantially airtight seal, such that the user can easily draw breathable air 21 from the sides, top, and bottom of the mask when the mask is worn. The mask is preferably 22 made up of a plurality of stacked layers having the same or substantially equivalent outer 23 dimensions, where the filter body and compressible gasket are two of the stacked layers. The 24 mask is preferably a respirator (e.g., a N95 respirator), however, in certain embodiments, the mask is a face shield, a face mask, a surgical mask, a filter mask, a mouth mask, or a gas 26 mask. In certain embodiments, the mask is a N95 respirator, a N98 respirator, or even a N99 27 respirator.
28 In certain embodiments, the mask further comprises an outer cover scrim comprising an 29 active agent, the outer cover scrim forming the outermost layer of the mask and configured to be exposed to the user's environment when the mask is worn. The active agent is preferably a 31 biocidal iodinated resin. In alternative embodiments, the active agent comprises triclosan (a 32 polychloro phenoxy phenol), diatomic halogen, silver, copper, zeolyte with an antimicrobial 22115965.1 3 Agent Ref: 69308/00006 1 attached thereto, halogenated resin, or other agent capable of devitalizing/deactivating 2 microorganisms/toxins such as activated carbon, phenol (carbolic acid) compounds, terpenes, 3 other metals, certain acids and bases, and other chemical compounds. It is preferred that the 4 outer cover scrim is coated with the active agent on at least a portion of its outer facing side, such that the active agent prevents surface contamination. In certain embodiments, however, 6 the active agent may be embedded within a matrix of the outer cover scrim and/or may be 7 incorporated in fibers of the outer cover scrim. In preferred embodiments, the filter body is 8 surrounded by the outer cover scrim as well as a face side cover scrim on the opposite side of 9 the filter body. Preferably, the outer cover scrim and face side cover scrim are each between about 0.1 and about 0.2 mm in thickness. The outer cover scrim and/or face side cover scrim 11 preferably comprise spunbond media, for example, spunbond polypropylene, polyethylene, 12 polyethylene terephthalate, or other polymer.
13 In certain embodiments, the filter body comprises a meltblown nonwoven material, 14 and/or the compressible gasket comprises triboelectric media. It is found that the triboelectric compressible gasket can be made of at least two different types of fiber (e.g., polypropylene 16 fiber and modacrylic fiber) such that a long-lasting inherent charge exists and no additional 17 charge need be applied to the gasket to enhance filtration performance. In certain 18 embodiments where self-cleaning of the filter body and/or compressible gasket is desired (e.g., 19 killing of filtered microorganisms such as viruses, mold spores, and bacteria), it is preferred that at least one of the filter body and the compressible gasket comprises a biocidal active agent that 21 kills microorganisms filtered from the air. Use of an iodinated resin as the biocidal active agent 22 shows particular advantages. The active agent may be embedded in the fiber matrix and/or 23 incorporated in the fibers of the filter body and/or the compressible gasket.
24 The filtering material of the compressible gasket has a high loft and provides a 3D
porous structure to sufficiently filter air that is drawn in from the top, bottom, and sides of the 26 mask when in use. The gasket is designed not to cover the mouth and nostrils of the wearer, 27 thereby providing enhanced comfort due to lower inhalation and exhalation resistance, yet the 28 gasket his high enough loft and the airpath therethrough is convoluted and long enough to 29 cause air drawn in from the top, bottom, and sides of the mask to be effectively filtered before being inhaled by the user. The compressible gasket has a desired thickness of at least about 31 1.5 mm, and more preferably at least about 2.5 mm. In certain embodiments, the compressible 32 gasket has a thickness within a range from about 1 mm to about 10 mm, preferably from about 33 2 mm to about 5 mm, and more preferably from about 2.5 mm to about 3.5 mm.
The filter body 22115965.1 4 Agent Ref. 69308/00006 1 has a desired thickness within a range from about 0.1 mm to about 0.3 mm. It is preferred that 2 the filter body be thinner than the compressible gasket to enhance comfort and reduce 3 inhalation and exhalation resistance. In certain embodiments, the filter body is at least about 5 4 times thinner, or, more preferably, at least about 10 times thinner than the compressible gasket.
In preferred embodiments, the compressible gasket defines an interior opening such that 6 the porous dielectric filtering material of the gasket does not cover the mouth and/or nose of the 7 user when the mask is worn. It is desired that the compressible gasket has a width measured 8 from the outer edge to the interior opening in a direction perpendicular to the edge of at least 9 about 1 cm. In certain embodiments, this width is at least about 1.5 cm, or more preferably at least about 2 cm. In preferred embodiments, this width is within a range from about 1.5 cm to 11 about 3 cm, and more preferably from about 2 cm to about 2.5 cm. Given a particular loft and 3-12 D (convoluted) pore structure, the gasket should have a width great enough to provide sufficient 13 filtration of air drawn from the top, bottom, and sides of the mask.
14 The dielectric filtering material of the compressible gasket preferably has a quasi-permanent electrostatic charge. Moreover, the nonwoven filtering substrate of the filter body 16 (e.g., meltblown polypropylene) has a quasi-permanent electrostatic charge.
17 Because of the unique design of the mask, it is able to achieve outstanding filtration 18 efficiency while maintaining excellent breathability (low inhalation and exhalation resistance). In 19 preferred embodiments, the mask has initial inhalation resistance at 85 I/min of less than 35 mm H2O and initial exhalation resistance at 85 I/min of less than 25 mm H2O; more preferably, the 21 mask has initial inhalation resistance at 85 Ipm of less than 15 mm H2O and initial exhalation 22 resistance at 85 I/min of less than 15 mm H2O; and even more preferably, the mask has mean 23 initial inhalation resistance at 85 Ipm of less than 10 mm H2O and mean initial exhalation 24 resistance at 85 I/min of less than 10 mm H2O. In preferred embodiments, the differential pressure is less than 5 mm H20/cm2, and preferably less than 3.5 mm H2O/cm2 (e.g., as 26 measured perASTM F2100). In addition to the low inhalation and exhalation resistance (less 27 than 35 mm H2O and 25 mm H2O respectively), the mask has NaCl penetration at 85 I/min of 28 less than 5.0%, preferably less than 3.0%. More preferably, the mask has a mean NaCl 29 penetration at 85 I/min of less than 2.0%, or even more preferably, less than 1.0%. Values of exhalation resistance, inhalation resistance, and NaCl penetration (0.3 micron NaCl particles) 31 refer to testing performed per NIOSH Procedure # RCT-APR-STP-0057, 0058, and 0059, using 32 TSI 8130 equipment. It is preferred that the mask also have sub-micron particulate filtration 22115965.1 5 Agent Ref: 69308/00006 1 efficiency of greater than or equal to 98%, and preferably greater than or equal to 99%, and 2 more preferably greater than or equal to 99.8% (e.g., using 0.1 micron Latex spheres, ASTM
3 F1215). It is also preferable that the mask demonstrate a bacterial filtration efficiency (BFE) of 4 at least 98%, more preferably greater than 99%, and more preferably greater than 99.9% (e.g., Staphylococcus aureus challenge, ASTM F2101). Furthermore, it is preferable that the mask 6 demonstrate a viral filtration efficiency (VFE) of at least 98%, more preferably greater than 99%, 7 and more preferably greater than 99.9% (e.g., PhiX 174 challenge, ASTM F2101 Modified).
8 Example test methods are based on ASTM F2100, Standard Specification for Performance of 9 Materials Used in Medical Face Masks.
For certain embodiments in which the mask contains iodinated resin (e.g., on the surface 11 of the outer cover scrim), it is preferred that the mask demonstrate antimicrobial activity, e.g., a 12 reduction of one or more of the following by at least 99% after a contact time of 15 minutes:
13 Staphylococcus aureus MRSA, Vancomycin-Resistant Enterococcus faecalis (VRE), 14 Escherichia coli, Klebsiella pneumoniae, Influenza A H1N1, and Bacteriophage MS2 Coliphage.
BRIEF DESCRIPTION OF DRAWINGS
16 FIG. Ia illustrates a front view of a facemask, according to an illustrative embodiment of 17 the invention.
18 FIG. lb illustrates an alternative front view of the facemask of FIG. la with the filter body 19 peeled partially away, according to an illustrative embodiment of the invention.
FIG. 2 illustrates a backside view of the facemask, according to an illustrative 21 embodiment of the invention.
22 FIG. 3 illustrates a back view of the facemask having a differently-shaped compressible 23 gasket, according to an illustrative embodiment of the invention.
24 FIG. 4 illustrates a facemask when in use, according to an illustrative embodiment of the invention.
26 FIGS. 5A-C illustrate a backside view, bottom view and a side view, respectively. of a 27 facemask, according to an illustrative embodiment of the invention.
22115965.1 6 Agent Ref: 69308/00006 1 FIG. 6 illustrates a front view of the facemask with outer cover scrim and face side cover 2 scrim, according to an illustrative embodiment of the invention.
3 FIG. 7 illustrates a front view of the facemask with outer cover scrim, according to an 4 illustrative embodiment of the invention.
DETAILED DESCRIPTION OF THE INVENTION
6 The following sections describe exemplary embodiments of the present invention. It 7 should be apparent to those skilled in the art that the described embodiments of the present 8 invention provided herein are illustrative only and not limiting, having been presented by way of 9 example only.
Throughout the description, where items are described as having, including, or 11 comprising one or more specific components, or where processes and methods are described 12 as having, including, or comprising one or more specific steps, it is contemplated that, 13 additionally, there are items of the present invention that consist essentially of, or consist of, the 14 one or more recited components, and that there are processes and methods according to the present invention that consist essentially of, or consist of, the one or more recited processing 16 steps.
17 The present invention relates generally to a facemask that has outstanding filtering 18 capacity and provides a high-level of comfort to the wearer. The facemask includes a filter body 19 and a compressible gasket attached to the periphery of the filter body. The filter body includes at least one layer of a nonwoven media that is capable of filtering particles.
As described below, 21 the filter body may also include an active agent capable of devitalizing microbes and other air-22 borne contaminants. The compressible gasket is preferably a high loft three-dimensional 23 material that when in use, is in contact with the face of the wearer. The compressible gasket is 24 designed to create a breathable closure that covers all the contours of the different geometrical surfaces of the face. Importantly, the compressible gasket is comprised of a filtering material 26 that is permeable to air. Hence, rather than forming an airtight seal, the compressible gasket 27 allows inhaled or exhaled air to pass through. Any air that passes through the top, bottom or 28 sides of the mask must pass through the compressible gasket, where it is effectively filtered.
29 Moreover, any air passing through the front of the mask will pass through the filter body, where it is filtered.
22115965.1 7 Agent Ref: 69308/00006 1 FIGS. Ia and 1b illustrate one embodiment of the facemask of the present invention.
2 These figures show a front view of the facemask. As depicted in FIG. 1a, the facemask 10 3 includes filter body 11, compressible gasket 12, head straps 13 and flexible nosepiece 14. The 4 dimensions of the facemask may vary and will be dependent on the shape and size of the face of a wearer. Generally, the width of the masks may range from about 13 cm to about 19 cm, 6 more preferably from about 14 cm to about 17.5 cm and most preferably from about 15 cm to 7 about 17 cm. The height of the mask ranges preferably from about 7 cm to about 11 cm, and 8 more preferably from about 8 cm to about 10 cm, and most preferably from about 8.5 cm to 9 about 9.5 cm. In one particularly preferred embodiment, the facemask has dimensions of 15. 8 cm x 8.5 cm. In another particularly preferred embodiment, the facemask has dimensions of 17 11 cm x 9.5 cm. Because of the unique design of the compressible gasket, the mask need not be 12 customized for an individual wearer. For example, it may be sufficient that only a few sizes 13 (e.g., three or even two) are needed to fit a very wide range of individuals. This eliminates the 14 need to produce many different mask sizes and therefore reduces manufacturing costs.
The filter body 11 is preferably comprised of a substrate, preferably a nonwoven fabric.
16 Nonwoven is a type of fabric that is bonded together rather than being spun and woven into a 17 cloth. It may be a manufactured sheet, mat, web or batt of directionally or randomly oriented 18 fibers bonded by friction or adhesion; it may take the form of a type of fabric. Preferred 19 nonwoven filter media include but are not limited to nylon, polyethylene, polypropylene, polyethylene terephthalate, polyester, etc. or any other polymer suitable for a filter substrate. In 21 such cases, it is preferable that the filter media be prepared from a meltblown process, which 22 provides for optimum filtration performance. Additionally, the filter body 11 can be made of 23 materials other than polymer fiber. For example, the filter body 11 may be made from 24 alternative substrates, which include glass fibers and fibers, such as cellulose, that are ultimately formed into a paper-based filter media. Cellulose fibers may be appropriate where 26 the mask is designed for single use.
27 The thickness of the filter body may range from about 0.1 mm to 0.25 mm, and more 28 preferably from about 0.13 mm to about 0.19 mm. The density of the filter body 11 preferably 29 ranges from about 20 grams/square meter (gsm) to about 40 gsm, and more preferably from about 30 gsm to about 40 gsm.
31 In one embodiment, an electrostatic charge is applied to filter body 11, thereby forming 32 an electret. The electrostatic charge enhances the filtration capacity of filter body 11. When a 22115965.1 8 Agent Ref: 69308/00006 1 charge is applied, there is a potential across the surface(s) of the filter body 11 creating a field.
2 The field can attract and/or repel charged particles introduced to the media so that in some 3 instances it alters the path of travel of the charged particles. The charge may be induced by 4 using a corona, needle punching, chemical enhancement, any other known charge inducing system or method, or a combination of any of the foregoing. Needle punching creates high-6 level friction, thus adding a charge. In a particular embodiment, to make the electrostatically 7 charged non-woven fabric the formed media, such as felt, is placed into a corona system of 8 about 25Kv, slow pass, until fully charged.
9 It is found that the triboelectric compressible gasket can be made of at least two different types of fiber (e.g., polypropylene fiber and modacrylic fiber) such that a long-lasting inherent 11 charge exists and no additional charge need be applied to the gasket to enhance filtration 12 performance.
13 In another embodiment, an active agent may be adhered to or incorporated in filter body 14 11. The active agent of the present invention may be, for example, an antimicrobial, an antitoxin, or the like. The antimicrobial may be biostatic and/or biocidal.
Biostatic is a material 16 that inhibits the growth of all or some of bacteria spores, viruses, fungi, etc. (having bioactive 17 particles), and a biocidal is a material that kills all or some of bacteria spores, viruses, fungi, etc.
18 The antimicrobial agent may be applied to a filter body that is electrically charged. The 19 combination of an electret and an active agent provides enhanced filtration capacity.
The prior art teaches against use of antibacterial with electrostatically charged filtration 21 media because of the deleterious effect the antibacterial has on charge over time, thereby 22 reducing filtration efficiency. However, it is surprisingly found that iodinated resin active agent 23 described herein actually preserves the electrostatic charge of the electret media, thereby 24 maintaining its high filtration efficiency. Not only does the iodinated resin pose no deleterious effect on charge, it is observed that the charge stability is actually enhanced by the presence of 26 the iodinated resin.
27 Thus, a preferred biocidal agent is a demand disinfectant iodinated resin.
Iodine/resin 28 demand disinfectants are described, for example, in U.S. Patent No.
BACKGROUND OF INVENTION
6 There are a variety of different types of facemasks that are commercially available (as 7 used herein, the terms "mask" and "facemask" are used interchangeably and include, without 8 limitation, face masks, respirators, face shields, surgical masks, filter masks, mouth masks, and 9 gas masks). These facemasks serve various functions which include providing protection from splashes and filtering air-borne contaminants, including pathogens. Facemasks differ 11 substantially in their filtering capacity and their comfort level. Loose fitting facemasks generally 12 provide a significant level of comfort at the expense of filtration ability. As such, these 13 facemasks provide little more than splash protection. On the other hand, facemasks that are 14 designed to have excellent filtering properties do not provide a sufficient level of comfort.
Accordingly, developing a comfortable facemask that has desirable filtration capacity is a 16 long-standing goal. One of the problems facing present filtering facemasks is providing a proper 17 fit to a wide variety of individual wearers such than an airtight seal is maintained about the 18 periphery of the mask, forcing all inhaled air to travel through the filter. There are a wide range 19 of face shapes, and it is therefore difficult to manufacture a facemask that maintains a 100%
airtight seal between the skin and the mask for a wide variety of individuals Various different 21 technological means have been tried, such as using adhesive seals, flat and wide seals, and 22 resilient material seals. The function of these seals is to prevent air from penetrating the top, 23 bottom and sides of the mask (i.e., the periphery of the mask). Ideally, all of the breathable air 24 passes through the front of the mask and is filtered, while the periphery of the mask is sealed against the face with a substantially "airtight" seal to prevent breathable air flow there through.
26 However, in these masks, the pressure differential generated at the periphery of the 27 mask actually forces air into gaps which form from time to time between the seal and skin, thus 28 bypassing the air filter material. Thus, a sufficient quantity of unfiltered air still gets through the 29 top, bottom and sides of the mask. Consider a user wearing an airtight-sealing facemask - the user would experience the pressure differential as a suction holding the mask against the user's 22115965.1 1 Agent Ref: 69308/00006 1 face with an airtight seal formed around the edge of the mask. If the mask does not properly fit 2 a given user, the airtight seal may fail to engage and render the user unprotected, since most of 3 the air breathed in will be unfiltered air from the gap in the seal. If the mask fits properly and 4 initially creates an airtight seal, the seal may become compromised by any gap that forms between the user's face and the edge of the mask due to movement of the user's face while 6 wearing the mask. In this case, the pressure differential between the exterior and interior of the 7 mask may actually promote entry of unfiltered air into the mask any time the seal is broken.
8 This unfiltered air is then breathed in by the user, thereby defeating the purpose of the 9 facemask.
Moreover, the airtight seal at the periphery of the mask renders the mask uncomfortable 11 and makes communication difficult. Some wearers complain of a "suction"
that causes 12 temporary marks on the face. Also, masks which form an airtight seal against the face may 13 cause breathing air to be unpleasantly warm or humid. The majority of advances in the 14 facemask industry have involved attempts to improve the filtering properties of facemasks by creating an improved airtight seal. However, these facemasks all, to some degree, suffer from 16 the same drawbacks as described above. Wearer discomfort may result in noncompliance with 17 respirator use rules of a particular establishment.
18 Given the shortcomings of the prior art, there exists a need for a new facemask that has 19 outstanding filtering capacity and provides a high level of comfort to the wearer. The mask should be able to filter and/or deactivate a large array of microbes and other dangerous 21 contaminants.
23 The present invention overcomes the aforementioned problems of the prior art. The 24 invention is directed to a protective mask that has high filtration efficiency, yet is easy to breathe through and is comfortable to wear. The mask includes a thin filter body layer configured to 26 cover the mouth and nose of a user when the mask is worn and a thicker compressible gasket 27 positioned along a periphery of the mask. The gasket comprises a high loft, porous dielectric 28 filtering material that forms a breathable seal/closure about the user's face without forming an 29 airtight seal, such that the user can draw breathable air from the sides, top, and bottom of the mask. The mask preferably includes an outer scrim coated with biocidal iodinated resin to 31 provide surface antibacterial properties.
22115965.1 2 Agent Ref: 69308/00006 1 There is no airtight or even semi-airtight seal formed around the periphery of the mask.
2 The user simply breathes in air that freely passes through the high loft breathable dielectric 3 filtering material that forms the compressible gasket around the periphery of the mask and 4 conforms to the user's face. The user also can breathe air directly through the center of the mask (interior to the gasket filter material), which is also filtered. Because there is no airtight 6 seal, there is no excessive pressure difference between the exterior and interior of the mask.
7 The high loft material conforms to the face of the user, and can accommodate a wide variety of 8 face shapes, as well as the movement of faces during use.
9 The compressible gasket is comprised of a three-dimensional breathable material which is designed to abut the face of a wearer. The compressible gasket does not create an airtight 11 junction but rather is designed to allow breathable air to pass through while providing a sufficient 12 level of comfort to the wearer. The air passing through the compressible gasket is effectively 13 filtered.
14 In one aspect, the invention is directed to a protective mask for filtering and/or deactivating contaminants in air, the mask including: a filter body comprising a nonwoven 16 filtering substrate, the filter body configured to cover the mouth and nose of a user when the 17 mask is worn; and a compressible gasket comprising a high loft, porous dielectric filtering 18 material, the gasket positioned along a periphery of the mask, the gasket configured to abut the 19 user's face when the mask is worn, thereby forming a breathable closure without forming an airtight or even a substantially airtight seal, such that the user can easily draw breathable air 21 from the sides, top, and bottom of the mask when the mask is worn. The mask is preferably 22 made up of a plurality of stacked layers having the same or substantially equivalent outer 23 dimensions, where the filter body and compressible gasket are two of the stacked layers. The 24 mask is preferably a respirator (e.g., a N95 respirator), however, in certain embodiments, the mask is a face shield, a face mask, a surgical mask, a filter mask, a mouth mask, or a gas 26 mask. In certain embodiments, the mask is a N95 respirator, a N98 respirator, or even a N99 27 respirator.
28 In certain embodiments, the mask further comprises an outer cover scrim comprising an 29 active agent, the outer cover scrim forming the outermost layer of the mask and configured to be exposed to the user's environment when the mask is worn. The active agent is preferably a 31 biocidal iodinated resin. In alternative embodiments, the active agent comprises triclosan (a 32 polychloro phenoxy phenol), diatomic halogen, silver, copper, zeolyte with an antimicrobial 22115965.1 3 Agent Ref: 69308/00006 1 attached thereto, halogenated resin, or other agent capable of devitalizing/deactivating 2 microorganisms/toxins such as activated carbon, phenol (carbolic acid) compounds, terpenes, 3 other metals, certain acids and bases, and other chemical compounds. It is preferred that the 4 outer cover scrim is coated with the active agent on at least a portion of its outer facing side, such that the active agent prevents surface contamination. In certain embodiments, however, 6 the active agent may be embedded within a matrix of the outer cover scrim and/or may be 7 incorporated in fibers of the outer cover scrim. In preferred embodiments, the filter body is 8 surrounded by the outer cover scrim as well as a face side cover scrim on the opposite side of 9 the filter body. Preferably, the outer cover scrim and face side cover scrim are each between about 0.1 and about 0.2 mm in thickness. The outer cover scrim and/or face side cover scrim 11 preferably comprise spunbond media, for example, spunbond polypropylene, polyethylene, 12 polyethylene terephthalate, or other polymer.
13 In certain embodiments, the filter body comprises a meltblown nonwoven material, 14 and/or the compressible gasket comprises triboelectric media. It is found that the triboelectric compressible gasket can be made of at least two different types of fiber (e.g., polypropylene 16 fiber and modacrylic fiber) such that a long-lasting inherent charge exists and no additional 17 charge need be applied to the gasket to enhance filtration performance. In certain 18 embodiments where self-cleaning of the filter body and/or compressible gasket is desired (e.g., 19 killing of filtered microorganisms such as viruses, mold spores, and bacteria), it is preferred that at least one of the filter body and the compressible gasket comprises a biocidal active agent that 21 kills microorganisms filtered from the air. Use of an iodinated resin as the biocidal active agent 22 shows particular advantages. The active agent may be embedded in the fiber matrix and/or 23 incorporated in the fibers of the filter body and/or the compressible gasket.
24 The filtering material of the compressible gasket has a high loft and provides a 3D
porous structure to sufficiently filter air that is drawn in from the top, bottom, and sides of the 26 mask when in use. The gasket is designed not to cover the mouth and nostrils of the wearer, 27 thereby providing enhanced comfort due to lower inhalation and exhalation resistance, yet the 28 gasket his high enough loft and the airpath therethrough is convoluted and long enough to 29 cause air drawn in from the top, bottom, and sides of the mask to be effectively filtered before being inhaled by the user. The compressible gasket has a desired thickness of at least about 31 1.5 mm, and more preferably at least about 2.5 mm. In certain embodiments, the compressible 32 gasket has a thickness within a range from about 1 mm to about 10 mm, preferably from about 33 2 mm to about 5 mm, and more preferably from about 2.5 mm to about 3.5 mm.
The filter body 22115965.1 4 Agent Ref. 69308/00006 1 has a desired thickness within a range from about 0.1 mm to about 0.3 mm. It is preferred that 2 the filter body be thinner than the compressible gasket to enhance comfort and reduce 3 inhalation and exhalation resistance. In certain embodiments, the filter body is at least about 5 4 times thinner, or, more preferably, at least about 10 times thinner than the compressible gasket.
In preferred embodiments, the compressible gasket defines an interior opening such that 6 the porous dielectric filtering material of the gasket does not cover the mouth and/or nose of the 7 user when the mask is worn. It is desired that the compressible gasket has a width measured 8 from the outer edge to the interior opening in a direction perpendicular to the edge of at least 9 about 1 cm. In certain embodiments, this width is at least about 1.5 cm, or more preferably at least about 2 cm. In preferred embodiments, this width is within a range from about 1.5 cm to 11 about 3 cm, and more preferably from about 2 cm to about 2.5 cm. Given a particular loft and 3-12 D (convoluted) pore structure, the gasket should have a width great enough to provide sufficient 13 filtration of air drawn from the top, bottom, and sides of the mask.
14 The dielectric filtering material of the compressible gasket preferably has a quasi-permanent electrostatic charge. Moreover, the nonwoven filtering substrate of the filter body 16 (e.g., meltblown polypropylene) has a quasi-permanent electrostatic charge.
17 Because of the unique design of the mask, it is able to achieve outstanding filtration 18 efficiency while maintaining excellent breathability (low inhalation and exhalation resistance). In 19 preferred embodiments, the mask has initial inhalation resistance at 85 I/min of less than 35 mm H2O and initial exhalation resistance at 85 I/min of less than 25 mm H2O; more preferably, the 21 mask has initial inhalation resistance at 85 Ipm of less than 15 mm H2O and initial exhalation 22 resistance at 85 I/min of less than 15 mm H2O; and even more preferably, the mask has mean 23 initial inhalation resistance at 85 Ipm of less than 10 mm H2O and mean initial exhalation 24 resistance at 85 I/min of less than 10 mm H2O. In preferred embodiments, the differential pressure is less than 5 mm H20/cm2, and preferably less than 3.5 mm H2O/cm2 (e.g., as 26 measured perASTM F2100). In addition to the low inhalation and exhalation resistance (less 27 than 35 mm H2O and 25 mm H2O respectively), the mask has NaCl penetration at 85 I/min of 28 less than 5.0%, preferably less than 3.0%. More preferably, the mask has a mean NaCl 29 penetration at 85 I/min of less than 2.0%, or even more preferably, less than 1.0%. Values of exhalation resistance, inhalation resistance, and NaCl penetration (0.3 micron NaCl particles) 31 refer to testing performed per NIOSH Procedure # RCT-APR-STP-0057, 0058, and 0059, using 32 TSI 8130 equipment. It is preferred that the mask also have sub-micron particulate filtration 22115965.1 5 Agent Ref: 69308/00006 1 efficiency of greater than or equal to 98%, and preferably greater than or equal to 99%, and 2 more preferably greater than or equal to 99.8% (e.g., using 0.1 micron Latex spheres, ASTM
3 F1215). It is also preferable that the mask demonstrate a bacterial filtration efficiency (BFE) of 4 at least 98%, more preferably greater than 99%, and more preferably greater than 99.9% (e.g., Staphylococcus aureus challenge, ASTM F2101). Furthermore, it is preferable that the mask 6 demonstrate a viral filtration efficiency (VFE) of at least 98%, more preferably greater than 99%, 7 and more preferably greater than 99.9% (e.g., PhiX 174 challenge, ASTM F2101 Modified).
8 Example test methods are based on ASTM F2100, Standard Specification for Performance of 9 Materials Used in Medical Face Masks.
For certain embodiments in which the mask contains iodinated resin (e.g., on the surface 11 of the outer cover scrim), it is preferred that the mask demonstrate antimicrobial activity, e.g., a 12 reduction of one or more of the following by at least 99% after a contact time of 15 minutes:
13 Staphylococcus aureus MRSA, Vancomycin-Resistant Enterococcus faecalis (VRE), 14 Escherichia coli, Klebsiella pneumoniae, Influenza A H1N1, and Bacteriophage MS2 Coliphage.
BRIEF DESCRIPTION OF DRAWINGS
16 FIG. Ia illustrates a front view of a facemask, according to an illustrative embodiment of 17 the invention.
18 FIG. lb illustrates an alternative front view of the facemask of FIG. la with the filter body 19 peeled partially away, according to an illustrative embodiment of the invention.
FIG. 2 illustrates a backside view of the facemask, according to an illustrative 21 embodiment of the invention.
22 FIG. 3 illustrates a back view of the facemask having a differently-shaped compressible 23 gasket, according to an illustrative embodiment of the invention.
24 FIG. 4 illustrates a facemask when in use, according to an illustrative embodiment of the invention.
26 FIGS. 5A-C illustrate a backside view, bottom view and a side view, respectively. of a 27 facemask, according to an illustrative embodiment of the invention.
22115965.1 6 Agent Ref: 69308/00006 1 FIG. 6 illustrates a front view of the facemask with outer cover scrim and face side cover 2 scrim, according to an illustrative embodiment of the invention.
3 FIG. 7 illustrates a front view of the facemask with outer cover scrim, according to an 4 illustrative embodiment of the invention.
DETAILED DESCRIPTION OF THE INVENTION
6 The following sections describe exemplary embodiments of the present invention. It 7 should be apparent to those skilled in the art that the described embodiments of the present 8 invention provided herein are illustrative only and not limiting, having been presented by way of 9 example only.
Throughout the description, where items are described as having, including, or 11 comprising one or more specific components, or where processes and methods are described 12 as having, including, or comprising one or more specific steps, it is contemplated that, 13 additionally, there are items of the present invention that consist essentially of, or consist of, the 14 one or more recited components, and that there are processes and methods according to the present invention that consist essentially of, or consist of, the one or more recited processing 16 steps.
17 The present invention relates generally to a facemask that has outstanding filtering 18 capacity and provides a high-level of comfort to the wearer. The facemask includes a filter body 19 and a compressible gasket attached to the periphery of the filter body. The filter body includes at least one layer of a nonwoven media that is capable of filtering particles.
As described below, 21 the filter body may also include an active agent capable of devitalizing microbes and other air-22 borne contaminants. The compressible gasket is preferably a high loft three-dimensional 23 material that when in use, is in contact with the face of the wearer. The compressible gasket is 24 designed to create a breathable closure that covers all the contours of the different geometrical surfaces of the face. Importantly, the compressible gasket is comprised of a filtering material 26 that is permeable to air. Hence, rather than forming an airtight seal, the compressible gasket 27 allows inhaled or exhaled air to pass through. Any air that passes through the top, bottom or 28 sides of the mask must pass through the compressible gasket, where it is effectively filtered.
29 Moreover, any air passing through the front of the mask will pass through the filter body, where it is filtered.
22115965.1 7 Agent Ref: 69308/00006 1 FIGS. Ia and 1b illustrate one embodiment of the facemask of the present invention.
2 These figures show a front view of the facemask. As depicted in FIG. 1a, the facemask 10 3 includes filter body 11, compressible gasket 12, head straps 13 and flexible nosepiece 14. The 4 dimensions of the facemask may vary and will be dependent on the shape and size of the face of a wearer. Generally, the width of the masks may range from about 13 cm to about 19 cm, 6 more preferably from about 14 cm to about 17.5 cm and most preferably from about 15 cm to 7 about 17 cm. The height of the mask ranges preferably from about 7 cm to about 11 cm, and 8 more preferably from about 8 cm to about 10 cm, and most preferably from about 8.5 cm to 9 about 9.5 cm. In one particularly preferred embodiment, the facemask has dimensions of 15. 8 cm x 8.5 cm. In another particularly preferred embodiment, the facemask has dimensions of 17 11 cm x 9.5 cm. Because of the unique design of the compressible gasket, the mask need not be 12 customized for an individual wearer. For example, it may be sufficient that only a few sizes 13 (e.g., three or even two) are needed to fit a very wide range of individuals. This eliminates the 14 need to produce many different mask sizes and therefore reduces manufacturing costs.
The filter body 11 is preferably comprised of a substrate, preferably a nonwoven fabric.
16 Nonwoven is a type of fabric that is bonded together rather than being spun and woven into a 17 cloth. It may be a manufactured sheet, mat, web or batt of directionally or randomly oriented 18 fibers bonded by friction or adhesion; it may take the form of a type of fabric. Preferred 19 nonwoven filter media include but are not limited to nylon, polyethylene, polypropylene, polyethylene terephthalate, polyester, etc. or any other polymer suitable for a filter substrate. In 21 such cases, it is preferable that the filter media be prepared from a meltblown process, which 22 provides for optimum filtration performance. Additionally, the filter body 11 can be made of 23 materials other than polymer fiber. For example, the filter body 11 may be made from 24 alternative substrates, which include glass fibers and fibers, such as cellulose, that are ultimately formed into a paper-based filter media. Cellulose fibers may be appropriate where 26 the mask is designed for single use.
27 The thickness of the filter body may range from about 0.1 mm to 0.25 mm, and more 28 preferably from about 0.13 mm to about 0.19 mm. The density of the filter body 11 preferably 29 ranges from about 20 grams/square meter (gsm) to about 40 gsm, and more preferably from about 30 gsm to about 40 gsm.
31 In one embodiment, an electrostatic charge is applied to filter body 11, thereby forming 32 an electret. The electrostatic charge enhances the filtration capacity of filter body 11. When a 22115965.1 8 Agent Ref: 69308/00006 1 charge is applied, there is a potential across the surface(s) of the filter body 11 creating a field.
2 The field can attract and/or repel charged particles introduced to the media so that in some 3 instances it alters the path of travel of the charged particles. The charge may be induced by 4 using a corona, needle punching, chemical enhancement, any other known charge inducing system or method, or a combination of any of the foregoing. Needle punching creates high-6 level friction, thus adding a charge. In a particular embodiment, to make the electrostatically 7 charged non-woven fabric the formed media, such as felt, is placed into a corona system of 8 about 25Kv, slow pass, until fully charged.
9 It is found that the triboelectric compressible gasket can be made of at least two different types of fiber (e.g., polypropylene fiber and modacrylic fiber) such that a long-lasting inherent 11 charge exists and no additional charge need be applied to the gasket to enhance filtration 12 performance.
13 In another embodiment, an active agent may be adhered to or incorporated in filter body 14 11. The active agent of the present invention may be, for example, an antimicrobial, an antitoxin, or the like. The antimicrobial may be biostatic and/or biocidal.
Biostatic is a material 16 that inhibits the growth of all or some of bacteria spores, viruses, fungi, etc. (having bioactive 17 particles), and a biocidal is a material that kills all or some of bacteria spores, viruses, fungi, etc.
18 The antimicrobial agent may be applied to a filter body that is electrically charged. The 19 combination of an electret and an active agent provides enhanced filtration capacity.
The prior art teaches against use of antibacterial with electrostatically charged filtration 21 media because of the deleterious effect the antibacterial has on charge over time, thereby 22 reducing filtration efficiency. However, it is surprisingly found that iodinated resin active agent 23 described herein actually preserves the electrostatic charge of the electret media, thereby 24 maintaining its high filtration efficiency. Not only does the iodinated resin pose no deleterious effect on charge, it is observed that the charge stability is actually enhanced by the presence of 26 the iodinated resin.
27 Thus, a preferred biocidal agent is a demand disinfectant iodinated resin.
Iodine/resin 28 demand disinfectants are described, for example, in U.S. Patent No.
5,639,452 ("the '452 29 patent"), to Messier, the entire contents of which are hereby incorporated by reference. The '452 patent describes a process for preparing an iodine demand disinfectant resin from an anion 31 exchange resin. The demand disinfectant iodinated resins described in the '452 patent may be 22115965.1 9 Agent Ref: 69308/00006 1 ground into a powder. One preferred demand disinfectant iodinated resin is Triosyn brand 2 iodinated resin powders made by Triosyn Research Inc., a division of Triosyn Corporation of 3 Vermont, USA. The particle sizes of the powders range from about 1 micron to about 150 4 microns. Preferably, the particle sizes should be in the range from about 4 microns to about 10 microns.
6 Triosyn iodinated resin powders used in accordance with the present invention are
7 referred to as Triosyn T-50 iodinated resin powder, Triosyn T-45 iodinated resin powder,
8 Triosyn T-40 iodinated resin powder or Triosyn T-35 iodinated resin powder. The base
9 polymer used to manufacture such iodinated resins is Amberlite 402 OH (Rohm & Haas).
These resins contain quaternary ammonium exchange groups with are bonded to styrenedivinyl 11 benzene polymer chains. Other base polymers could be used. The numbers refer to the 12 approximate weight percentage of iodine relative to the resin. Powders with other weight 13 percentages of iodine may also be used in accordance with the present invention. Different 14 percentages of iodine in the iodinated resin powders will confer different properties to the powder, in particular, different levels of biocidal activity. The particular resin used is based on 16 the desired application. It is important to note that iodinated resin from other sources can also 17 be used.
18 The Triosyn iodinated resin may be adhered to the surface of filter body 11. For 19 instance, a mix of adhesive (e.g., glue) and water may be sprayed on the filter body 11 followed by drying. Next, a solution of water and Triosyn iodinated resin powder are sprayed onto the 21 surface of filter body 11. After drying, the iodinated resin powder adheres to the filter body 11.
22 In an alternative embodiment, the iodinated resin may be physically entrapped within the 23 interstitial matrix of the nonwoven fibers. Methods of physically entrapping iodinated resin 24 particulates in a nonwoven matrix are described in U.S. Patent Application No. 2006/0251879, which is hereby incorporated by reference. In another alternative embodiment, the iodinated 26 resin may be embedded within the fibers comprising the nonwoven material.
Methods of 27 embedding iodinated resin in fibers comprising a nonwoven matrix is described in U.S. Patent 28 Application No. 2009/0259158, which is hereby incorporated by reference.
29 Other active agents that may be used in addition to -- or, in alternative embodiments, instead of -- the iodinated resin include, but are not limited to, triclosan (a polychloro phenoxy 31 phenol), diatomic halogen, silver, copper, zeolyte with an antimicrobial attached thereto, 32 halogenated resin, or other agent capable of devitalizing/deactivating microorganisms/toxins 22115965.1 10 Agent Ref: 69308/00006 1 such as activated carbon, phenol (carbolic acid) compounds, terpenes, other metals, certain 2 acids and bases, and other chemical compounds.
3 Returning to FIG. 1a, the filter body 11 of facemask 10 is attached to compressible 4 gasket 12. The compressible gasket 12 is attached at the periphery of the filter body 11 and extends from the outer edge of the mask into the interior of the mask, defining an opening in the 6 interior large enough to accommodate the mouth and nostrils of the user (exemplary openings 7 can be seen in FIG. 1 b, 2, and 3). The gasket 12 may be attached to the filter body 11 by 8 various means. For instance, in one embodiment, the gasket 12 and filter body 11 are 9 ultrasonically welded. Alternatively, the two layers may be attached to each other by stitching and/or adhesive. The compressible gasket 12 can be seen clearly in FIG. 1 b, where a portion 11 of filter body 12 is partially peeled away for clarification purposes.
Additionally, a backside view 12 of facemask 10 is depicted in FIG. 2. A backside view of a facemask of the present invention 13 with an alternative configuration is illustrated in FIG. 3. It is noted that different configurations of 14 the facemask are made to accommodate different face sizes and shapes. The relative orientation of the compressible gasket 12 with respect to filter body 11 can clearly be seen in 16 FIGS. 2 and 3.
17 As illustrated in FIGS. 1b, 2 and 3, while the compressible gasket 12 occupies the 18 entirety of the periphery of the facemask, it extends only partially into the interior of the mask.
19 The width of the gasket 12 (measured from the outer edge in a direction perpendicular to the edge and toward the center of the mask) is in the range of about 1.0 - 5.0 cm, more preferably 21 from about 1.5 - 3.0 cm and most preferably from about 2.0- 2.5 cm. The thickness of the 22 gasket is in the range of about 1 mm to 10 mm, and preferably in the range of about 2 mm to 23 about 5 mm, and most preferably in the range of about 2.5 mm to 3.5 mm. In use (FIG. 4), the 24 compressible gasket 12 comfortably abuts the face of the wearer.
Additionally, the use of head straps 13 to hold the mask in place to compresses the gasket of the present invention to fit 26 essentially all faces. The filter body 11 occupies the space around the nose and mouth.
27 FIGS. 5a-c show a backside view bottom view and a side view, respectively, of a 28 facemask of the present invention. In can be appreciated from FIGS. 5b and Sc that the 29 compressible gasket 12 of facemask 10 is considerably thicker than the filtering body 13. The compressible gasket 12 is comprised of a breathable material that provides enhanced comfort 31 to the wearer. Additionally, the compressible gasket 12 is capable of filtering any air passing 32 through the top, bottom and sides of the mask. To achieve this, the filtering material is 22115965.1 11 Agent Ref. 69308/00006 1 preferably made of a nonwoven media. Preferably, the compressible gasket 12 holds an 2 electrostatic charge. The electrical charge enhances the filtration efficiency of the nonwoven 3 media. A preferred example of a filtration media used to make the compressible gasket is a 4 triboelectric media. In the process of triboelectrification, electric charge is transferred between different pieces of different polymeric materials by contact or by friction.
The product obtained 6 by such contact of polymeric materials is referred to as a triboelectric media. Preferably, the 7 triboelectric media is comprised of a high loft material with a density in the range preferably from 8 about 200 gsm to about 400 gsm and more preferably in the range from about 250 gsm to about 9 300 gsm. A particularly preferred triboelectric media used in accordance with the present invention is comprised of polypropylene fibers and modacrylic fibers. It is found that where the 11 triboelectric compressible gasket is made of both polypropylene fiber and modacrylic fiber, a 12 long-lasting inherent charge exists and no additional charge need be applied to the gasket to 13 enhance filtration performance. As will be described in the Examples below, the combination of 14 the filter body 11 and the compressible gasket 12 provides the facemask with a filtration capacity needed to have at least a N95 NIOSH rating, and in some cases may provide masks 16 with a N98 or N99 rating.
17 Additionally, as with the filter body 10, compressible gasket 12 may contain an active 18 agent. The active agent may include but is not limited to an iodinated resin triclosan, diatomic 19 halogens, silver, copper, zeolyte with an antimicrobial attached thereto, halogenated resins, and agents capable of devitalizing/deactivating microorganisms/toxins that are known in the art, 21 including for example activated carbon, other metals and other chemical compounds. In one 22 embodiment, both an active agent and an electrical charge can be applied to the filter media.
23 As discussed above, compressible gasket 12 serves several important functions. The 24 compressible gasket 12 significantly reduces exposure to airborne particles which enter the mask from the top, sides and bottom. Because the gasket is not designed to form an airtight 26 seal, as with prior art facemasks, air is not forced through holes generated from an imperfect fit.
27 Instead, air is allowed to through the compressible gasket 12, where it is effectively filtered.
28 Accordingly, both the filter body 11 and the compressible gasket 12 are responsible for the 29 outstanding filtration properties of the mask. Moreover, the compressible gasket 12 is made from a breathable material and hence, has a low pressure drop across the media. The low 31 pressure drop translates do a high level of comfort, contrary to masks that are designed to form 32 an airtight seal at the periphery. Besides providing comfort, the facemasks of the present 33 invention allow the wearer to communicate effectively, which is quite contrary to masks 22115965.1 12 Agent Ref: 69308/00006 1 designed with an airtight seal. The ability to communicate effectively and comprehensibly while 2 wearing a facemask is particularly important in the medical profession.
3 Another embodiment of the facemask of the present invention is illustrated in FIG. 6.
4 The facemask 10 includes four distinct layers, a filter body 11, compressible gasket 12, an outer cover scrim 15 and a face side cover scrim 16. The outer cover scrim 15 and a face side cover 6 scrim 16 surround filter body 11. The individual layers are shown as partially peeled away for 7 clarity purposes. Facemask 10 also contains straps 13 and flexible nosepiece 14. In 8 alternative embodiments, the facemask 10 may include either an outer scrim 15 or a face side 9 cover scrim 16. The embodiment with a facemask having just the outer scrim 15 is illustrated in FIG. 7. Typical densities of the outer scrim 15 and face side cover scrim 16 range from about 11 20 gsm to about 80 gsm, and more preferably from about 30 gsm to about 40 gsm. The 12 thickness of both scrims range from about 0.1 mm to about 0.3 mm. Suitable materials for the 13 scrims include but are not limited to polypropylene, polyethylene, nylon, and polyester The 14 scrims are preferably made from a spunbond media. Most preferably, the outer scrim 15 and face side cover scrim 16 are comprised of thermal bond polypropylene. Both the outer cover 16 scrim 15 and face side cover scrim 16 provide the facemask 10 with additional bulk and offer an 17 extra layer of protection. In addition, the scrim(s) may be composed of fibers with greater 18 strength than fibers of the filter body, thereby adding strength to the overall mask and 19 preventing premature degradation of the filter body 11. The scrim(s) may also provide better adherence and stability of applied active agent, e.g., iodinated resin, than would be provided by 21 the filter body alone, and without affecting the filtering properties of the filter body. When face 22 side cover scrim 16 is present in the facemask 10, it rests against the nose and mouth of the 23 wearer and provides additional comfort.
24 Outer cover scrim 15 may contain an active agent. Preferred active agents include but are not limited to iodinated resin, triclosan, diatomic halogens, silver, copper, zeolyte with an 26 antimicrobial attached thereto, halogenated resins, and agents capable of 27 devitalizing/deactivating microorganisms/toxins that are known in the art, including for example 28 activated carbon, other metals and other chemical compounds. It has been found that adding 29 an iodinated resin to outer cover scrim 15 is particularly effective against a host of different microorganisms. In a preferred embodiment, the iodinated resin is adhered to the scrim using a 31 suitable adhesive. The surface concentration of iodinated resin is preferably within the range 32 from about 1 g/m2 to about 3.5 g/m2, for example, about 2 g/m2. The iodinated resin may be, for 33 example, Triosyn T-50 iodinated resin powder, Triosyn T-45 iodinated resin powder, 22115965.1 13 Agent Ref: 69308/00006 1 Triosyn T-40 iodinated resin powder or Triosyn T-35 iodinated resin powder. In one specific 2 example, the iodinated resin has an average particle size of about 10 micron, although other 3 particle sizes may be used. The adhesive used may be, for example, a water-based adhesive 4 such as Simalfa adhesive (e.g., made from acrylates copolymer and rubber latex), or the like, in an amount within the range from about 1 g/m2 to about 3.5 g/m2, for example, about 4 g/m2.
6 Since the outer cover scrim 15 is preferably a spunbond nonwoven material, the 7 iodinated resin can be adhered to the nonwoven media without affecting the properties of the 8 filter body 11. For instance, a mix of adhesive (e.g., glue) and water may be sprayed on the 9 outer cover scrim 15 followed by drying. Next, a solution of water and Triosyn iodinated resin powder are sprayed onto the surface of outer cover scrim 15. After drying, the iodinated resin 11 powder adheres to the outer cover scrim 15. Alternatively, the iodinated resin may be 12 embedded within the three-dimensional matrix of outer scrim 15. When the active agent (e.g., 13 iodinated resin) is present in the outer cover scrim 15, the surface of the facemask is rendered 14 toxic to a large away of different microbes and other contaminants.
Contamination of a mask surface may occur, for example, due to a splash of body fluids such as blood or sputum (e.g., in 16 a surgical, dental, or medical procedure setting), or by the touching of the mask by the wearer 17 with contaminated fingers or gloves. In these cases, the microbes first come into contact with 18 outer cover scrim 15, and they will be deactivated on contact with the active agent. As 19 discussed with respect to FIG. 1, additional active agent may be incorporated into filter body 11 to provide an additional level of protection against microbes and other contaminants. Because 21 the outer cover scrim 15 and face side cover scrim 16 are thin and highly air-permeable, they do 22 not pose a significant pressure drop and do not appreciably increase inhalation or exhalation 23 resistance.
24 When coupled with the outstanding filtration properties of the facemask of the present invention, the presence of a thin outer layer (e.g., scrim) containing an active agent (e.g., 26 iodinated resin) provides the inventive facemasks with multiple levels of protection. The masks 27 are comfortable to wear and could be produced at relatively low costs.
Additionally, the masks 28 are biocompatible and nontoxic to the wearer.
Facemasks prepared in accordance with embodiments of the present invention were 31 tested for filtration efficiency, inhalation and exhalation resistance and microbiological 22115965.1 14 Agent Ref: 69308/00006 1 performance. The facemasks tested contained a meltblown polypropylene filter body and a 2 compressible gasket comprised of a triboelectric polypropylene media. In addition, the 3 facemasks contained an outer cover scrim and a face side cover scrim made of spunbond 4 polypropylene. The face side cover scrim contained Triosyn T-50 iodinated resin powder adhered to its surface.
6 Filtration Efficiency 7 We determined whether facemasks produced in accordance with the present invention 8 are N95 respirators. A filtering facepiece respirator that filters out at least 95% of airborne 9 particles during "worse case" testing using a "most-penetrating" sized particle is given a 95 rating. There are nine classes of NIOSH-approved particulate filtering respirators available at 11 this time. 95% is the minimal level of filtration that will be approved by NIOSH. The N, R and P
12 designations refer to the filter's oil resistance: N filters are not resistant to oil, R filters are 13 somewhat resistant to oil, and P filters are strongly resistant to oil.
Testing protocols improved 14 with gaining N95 approval are well-known (see, for instance, S. Rengasamy, W.P. King, B.C.
Eimer and R.E. Shaffer (2008). Filtration performance of NIOSH-approved N95 and P100 16 filtering facepiece respirators against 4 to 30 nanometer-size nanoparticles. Journal of 17 Occupational and Environmental Hygiene 5(9):556-564, which is hereby incorporated by 18 reference).
19 To determine the filtration efficiency of the facemasks of the present invention, we used an NaCl penetration test. In the NaCl penetration test, an aerosol containing 0.3 micron NaCl 21 particles is flowed through the mask at a flow rate of 85 L/min. The testing was performed per 22 NIOSH Procedure # RCT-APR-STP-0057, 0058, and 0059. The TSI Automated Filter Tester 23 8130 was used to generate the data.
24 Two series up masks were tested. One series of masks are characterized as small/medium (S/M). The S/M masks have dimensions of 15.8 x 8.5 cm. The S/M
masks have 26 a meltblown polypropylene filter body 11 with 0.19 mm thickness, a triboelectric polypropylene 27 compressible gasket 12 with 2.69 mm thickness, a polypropylene outer cover scrim 15 with 0.16 28 mm thickness, and a thermal bond polypropylene face side cover scrim 16 with 0.10 mm 29 thickness.
The other series of masks are characterized as medium/large (M/L). The M/L
masks 31 have dimensions of 17 cm x 9.5 cm. The M/L masks have a meltblown polypropylene filter body 22115965.1 15 Agent Ref: 69308/00006 11 with 0.13 mm thickness, a triboelectric polypropylene compressible gasket 12 with 2.69 mm 2 thickness, a polypropylene outer cover scrim 15 with 0.19 mm thickness, and a thermal bond 3 polypropylene face side cover scrim 16 with 0.10 mm thickness.
4 Twenty individual masks from each series were tested. The results from the S/M series are shown in are shown in Table 1 and the results from the M/L series are shown in Table 2.
7 Table 1: Measure of Filtration Efficiency of the S/M Series of Inventive Facemasks NaCl penetration Sample At 851/min (5.00 % max) 1 0.960 2 1.32 3 1.21 4 0.702 5 1.38 6 2.02 7 1.14 8 1.38 9 0.851 1.15 11 2.43 12 1.42 13 2.23 14 2.25 2.52 16 1.59 17 1.22 18 2.33 19 2.70 1.69 Mean 1.62 Std Dev 0.605 22115965.1 16 Agent Ref: 69308/00006 Table 2: Measure of Filtration Efficiency of the M/L Series of Inventive Facemasks NaCl penetration Sample At 85 I/min (5.00 % max) 1 0.281 2 0.529 3 0.999 4 0.498 0.459 6 0.466 7 0.536 8 0.873 9 0.578 0.462 11 0.641 12 0.392 13 0.886 14 0.285 0.143 16 0.469 17 0.202 18 0.289 19 0.273 0.310 Mean 0.479 Std Dev 0.231 3 As shown in Table 1 for the S/M series of facemasks, on average, less than 2.0% of the 4 NaCl particles penetrated the facemasks. As shown in Table 2 for the M/L
series, less than 5 1.0% of the NaCl particles penetrated the facemasks. Hence, the inventive masks demonstrate 6 the filtration performance of at least N95 respirators, where a maximum of 5.0% of NaCl 7 penetration is permitted.
22115965.1 17 Agent Ref: 69308/00006 1 Inhalation and Exhalation Resistance 2 Tests were also conducted to determine inhalation and exhalation resistance of the 3 inventive facemasks. The tests performed were based on ASTM F2100 - Standard 4 Specification For Performance of Materials Used In Medical face Masks. A
value of 35 mm H2O (pressure) or greater indicates that resistance to inhalation is not acceptable. A value of 25 6 mm H2O (pressure) or greater indicates that resistance to exhalation is not acceptable. Results 7 of inhalation and exhalation resistance testing for the S/M series of facemasks of the present 8 invention are shown in Table 3. Results of inhalation and exhalation resistance testing for the 9 M/L series of facemasks of the present invention are shown in Table 4.
Table 3: Measure of Inhalation and Exhalation Resistance of the S/M Series of Inventive 11 facemasks Initial Inhalation Initial Exhalation Sample resistance at 85 Umin resistance at 85 Umin (mm water column) (mm water column) 1 8.5 8.4 2 9.0 8.8 3 8.9 8.7 4 9.6 9.4 5 10.0 9.8 6 8.6 8.4 7 8.8 8 8.3 9 9.8
These resins contain quaternary ammonium exchange groups with are bonded to styrenedivinyl 11 benzene polymer chains. Other base polymers could be used. The numbers refer to the 12 approximate weight percentage of iodine relative to the resin. Powders with other weight 13 percentages of iodine may also be used in accordance with the present invention. Different 14 percentages of iodine in the iodinated resin powders will confer different properties to the powder, in particular, different levels of biocidal activity. The particular resin used is based on 16 the desired application. It is important to note that iodinated resin from other sources can also 17 be used.
18 The Triosyn iodinated resin may be adhered to the surface of filter body 11. For 19 instance, a mix of adhesive (e.g., glue) and water may be sprayed on the filter body 11 followed by drying. Next, a solution of water and Triosyn iodinated resin powder are sprayed onto the 21 surface of filter body 11. After drying, the iodinated resin powder adheres to the filter body 11.
22 In an alternative embodiment, the iodinated resin may be physically entrapped within the 23 interstitial matrix of the nonwoven fibers. Methods of physically entrapping iodinated resin 24 particulates in a nonwoven matrix are described in U.S. Patent Application No. 2006/0251879, which is hereby incorporated by reference. In another alternative embodiment, the iodinated 26 resin may be embedded within the fibers comprising the nonwoven material.
Methods of 27 embedding iodinated resin in fibers comprising a nonwoven matrix is described in U.S. Patent 28 Application No. 2009/0259158, which is hereby incorporated by reference.
29 Other active agents that may be used in addition to -- or, in alternative embodiments, instead of -- the iodinated resin include, but are not limited to, triclosan (a polychloro phenoxy 31 phenol), diatomic halogen, silver, copper, zeolyte with an antimicrobial attached thereto, 32 halogenated resin, or other agent capable of devitalizing/deactivating microorganisms/toxins 22115965.1 10 Agent Ref: 69308/00006 1 such as activated carbon, phenol (carbolic acid) compounds, terpenes, other metals, certain 2 acids and bases, and other chemical compounds.
3 Returning to FIG. 1a, the filter body 11 of facemask 10 is attached to compressible 4 gasket 12. The compressible gasket 12 is attached at the periphery of the filter body 11 and extends from the outer edge of the mask into the interior of the mask, defining an opening in the 6 interior large enough to accommodate the mouth and nostrils of the user (exemplary openings 7 can be seen in FIG. 1 b, 2, and 3). The gasket 12 may be attached to the filter body 11 by 8 various means. For instance, in one embodiment, the gasket 12 and filter body 11 are 9 ultrasonically welded. Alternatively, the two layers may be attached to each other by stitching and/or adhesive. The compressible gasket 12 can be seen clearly in FIG. 1 b, where a portion 11 of filter body 12 is partially peeled away for clarification purposes.
Additionally, a backside view 12 of facemask 10 is depicted in FIG. 2. A backside view of a facemask of the present invention 13 with an alternative configuration is illustrated in FIG. 3. It is noted that different configurations of 14 the facemask are made to accommodate different face sizes and shapes. The relative orientation of the compressible gasket 12 with respect to filter body 11 can clearly be seen in 16 FIGS. 2 and 3.
17 As illustrated in FIGS. 1b, 2 and 3, while the compressible gasket 12 occupies the 18 entirety of the periphery of the facemask, it extends only partially into the interior of the mask.
19 The width of the gasket 12 (measured from the outer edge in a direction perpendicular to the edge and toward the center of the mask) is in the range of about 1.0 - 5.0 cm, more preferably 21 from about 1.5 - 3.0 cm and most preferably from about 2.0- 2.5 cm. The thickness of the 22 gasket is in the range of about 1 mm to 10 mm, and preferably in the range of about 2 mm to 23 about 5 mm, and most preferably in the range of about 2.5 mm to 3.5 mm. In use (FIG. 4), the 24 compressible gasket 12 comfortably abuts the face of the wearer.
Additionally, the use of head straps 13 to hold the mask in place to compresses the gasket of the present invention to fit 26 essentially all faces. The filter body 11 occupies the space around the nose and mouth.
27 FIGS. 5a-c show a backside view bottom view and a side view, respectively, of a 28 facemask of the present invention. In can be appreciated from FIGS. 5b and Sc that the 29 compressible gasket 12 of facemask 10 is considerably thicker than the filtering body 13. The compressible gasket 12 is comprised of a breathable material that provides enhanced comfort 31 to the wearer. Additionally, the compressible gasket 12 is capable of filtering any air passing 32 through the top, bottom and sides of the mask. To achieve this, the filtering material is 22115965.1 11 Agent Ref. 69308/00006 1 preferably made of a nonwoven media. Preferably, the compressible gasket 12 holds an 2 electrostatic charge. The electrical charge enhances the filtration efficiency of the nonwoven 3 media. A preferred example of a filtration media used to make the compressible gasket is a 4 triboelectric media. In the process of triboelectrification, electric charge is transferred between different pieces of different polymeric materials by contact or by friction.
The product obtained 6 by such contact of polymeric materials is referred to as a triboelectric media. Preferably, the 7 triboelectric media is comprised of a high loft material with a density in the range preferably from 8 about 200 gsm to about 400 gsm and more preferably in the range from about 250 gsm to about 9 300 gsm. A particularly preferred triboelectric media used in accordance with the present invention is comprised of polypropylene fibers and modacrylic fibers. It is found that where the 11 triboelectric compressible gasket is made of both polypropylene fiber and modacrylic fiber, a 12 long-lasting inherent charge exists and no additional charge need be applied to the gasket to 13 enhance filtration performance. As will be described in the Examples below, the combination of 14 the filter body 11 and the compressible gasket 12 provides the facemask with a filtration capacity needed to have at least a N95 NIOSH rating, and in some cases may provide masks 16 with a N98 or N99 rating.
17 Additionally, as with the filter body 10, compressible gasket 12 may contain an active 18 agent. The active agent may include but is not limited to an iodinated resin triclosan, diatomic 19 halogens, silver, copper, zeolyte with an antimicrobial attached thereto, halogenated resins, and agents capable of devitalizing/deactivating microorganisms/toxins that are known in the art, 21 including for example activated carbon, other metals and other chemical compounds. In one 22 embodiment, both an active agent and an electrical charge can be applied to the filter media.
23 As discussed above, compressible gasket 12 serves several important functions. The 24 compressible gasket 12 significantly reduces exposure to airborne particles which enter the mask from the top, sides and bottom. Because the gasket is not designed to form an airtight 26 seal, as with prior art facemasks, air is not forced through holes generated from an imperfect fit.
27 Instead, air is allowed to through the compressible gasket 12, where it is effectively filtered.
28 Accordingly, both the filter body 11 and the compressible gasket 12 are responsible for the 29 outstanding filtration properties of the mask. Moreover, the compressible gasket 12 is made from a breathable material and hence, has a low pressure drop across the media. The low 31 pressure drop translates do a high level of comfort, contrary to masks that are designed to form 32 an airtight seal at the periphery. Besides providing comfort, the facemasks of the present 33 invention allow the wearer to communicate effectively, which is quite contrary to masks 22115965.1 12 Agent Ref: 69308/00006 1 designed with an airtight seal. The ability to communicate effectively and comprehensibly while 2 wearing a facemask is particularly important in the medical profession.
3 Another embodiment of the facemask of the present invention is illustrated in FIG. 6.
4 The facemask 10 includes four distinct layers, a filter body 11, compressible gasket 12, an outer cover scrim 15 and a face side cover scrim 16. The outer cover scrim 15 and a face side cover 6 scrim 16 surround filter body 11. The individual layers are shown as partially peeled away for 7 clarity purposes. Facemask 10 also contains straps 13 and flexible nosepiece 14. In 8 alternative embodiments, the facemask 10 may include either an outer scrim 15 or a face side 9 cover scrim 16. The embodiment with a facemask having just the outer scrim 15 is illustrated in FIG. 7. Typical densities of the outer scrim 15 and face side cover scrim 16 range from about 11 20 gsm to about 80 gsm, and more preferably from about 30 gsm to about 40 gsm. The 12 thickness of both scrims range from about 0.1 mm to about 0.3 mm. Suitable materials for the 13 scrims include but are not limited to polypropylene, polyethylene, nylon, and polyester The 14 scrims are preferably made from a spunbond media. Most preferably, the outer scrim 15 and face side cover scrim 16 are comprised of thermal bond polypropylene. Both the outer cover 16 scrim 15 and face side cover scrim 16 provide the facemask 10 with additional bulk and offer an 17 extra layer of protection. In addition, the scrim(s) may be composed of fibers with greater 18 strength than fibers of the filter body, thereby adding strength to the overall mask and 19 preventing premature degradation of the filter body 11. The scrim(s) may also provide better adherence and stability of applied active agent, e.g., iodinated resin, than would be provided by 21 the filter body alone, and without affecting the filtering properties of the filter body. When face 22 side cover scrim 16 is present in the facemask 10, it rests against the nose and mouth of the 23 wearer and provides additional comfort.
24 Outer cover scrim 15 may contain an active agent. Preferred active agents include but are not limited to iodinated resin, triclosan, diatomic halogens, silver, copper, zeolyte with an 26 antimicrobial attached thereto, halogenated resins, and agents capable of 27 devitalizing/deactivating microorganisms/toxins that are known in the art, including for example 28 activated carbon, other metals and other chemical compounds. It has been found that adding 29 an iodinated resin to outer cover scrim 15 is particularly effective against a host of different microorganisms. In a preferred embodiment, the iodinated resin is adhered to the scrim using a 31 suitable adhesive. The surface concentration of iodinated resin is preferably within the range 32 from about 1 g/m2 to about 3.5 g/m2, for example, about 2 g/m2. The iodinated resin may be, for 33 example, Triosyn T-50 iodinated resin powder, Triosyn T-45 iodinated resin powder, 22115965.1 13 Agent Ref: 69308/00006 1 Triosyn T-40 iodinated resin powder or Triosyn T-35 iodinated resin powder. In one specific 2 example, the iodinated resin has an average particle size of about 10 micron, although other 3 particle sizes may be used. The adhesive used may be, for example, a water-based adhesive 4 such as Simalfa adhesive (e.g., made from acrylates copolymer and rubber latex), or the like, in an amount within the range from about 1 g/m2 to about 3.5 g/m2, for example, about 4 g/m2.
6 Since the outer cover scrim 15 is preferably a spunbond nonwoven material, the 7 iodinated resin can be adhered to the nonwoven media without affecting the properties of the 8 filter body 11. For instance, a mix of adhesive (e.g., glue) and water may be sprayed on the 9 outer cover scrim 15 followed by drying. Next, a solution of water and Triosyn iodinated resin powder are sprayed onto the surface of outer cover scrim 15. After drying, the iodinated resin 11 powder adheres to the outer cover scrim 15. Alternatively, the iodinated resin may be 12 embedded within the three-dimensional matrix of outer scrim 15. When the active agent (e.g., 13 iodinated resin) is present in the outer cover scrim 15, the surface of the facemask is rendered 14 toxic to a large away of different microbes and other contaminants.
Contamination of a mask surface may occur, for example, due to a splash of body fluids such as blood or sputum (e.g., in 16 a surgical, dental, or medical procedure setting), or by the touching of the mask by the wearer 17 with contaminated fingers or gloves. In these cases, the microbes first come into contact with 18 outer cover scrim 15, and they will be deactivated on contact with the active agent. As 19 discussed with respect to FIG. 1, additional active agent may be incorporated into filter body 11 to provide an additional level of protection against microbes and other contaminants. Because 21 the outer cover scrim 15 and face side cover scrim 16 are thin and highly air-permeable, they do 22 not pose a significant pressure drop and do not appreciably increase inhalation or exhalation 23 resistance.
24 When coupled with the outstanding filtration properties of the facemask of the present invention, the presence of a thin outer layer (e.g., scrim) containing an active agent (e.g., 26 iodinated resin) provides the inventive facemasks with multiple levels of protection. The masks 27 are comfortable to wear and could be produced at relatively low costs.
Additionally, the masks 28 are biocompatible and nontoxic to the wearer.
Facemasks prepared in accordance with embodiments of the present invention were 31 tested for filtration efficiency, inhalation and exhalation resistance and microbiological 22115965.1 14 Agent Ref: 69308/00006 1 performance. The facemasks tested contained a meltblown polypropylene filter body and a 2 compressible gasket comprised of a triboelectric polypropylene media. In addition, the 3 facemasks contained an outer cover scrim and a face side cover scrim made of spunbond 4 polypropylene. The face side cover scrim contained Triosyn T-50 iodinated resin powder adhered to its surface.
6 Filtration Efficiency 7 We determined whether facemasks produced in accordance with the present invention 8 are N95 respirators. A filtering facepiece respirator that filters out at least 95% of airborne 9 particles during "worse case" testing using a "most-penetrating" sized particle is given a 95 rating. There are nine classes of NIOSH-approved particulate filtering respirators available at 11 this time. 95% is the minimal level of filtration that will be approved by NIOSH. The N, R and P
12 designations refer to the filter's oil resistance: N filters are not resistant to oil, R filters are 13 somewhat resistant to oil, and P filters are strongly resistant to oil.
Testing protocols improved 14 with gaining N95 approval are well-known (see, for instance, S. Rengasamy, W.P. King, B.C.
Eimer and R.E. Shaffer (2008). Filtration performance of NIOSH-approved N95 and P100 16 filtering facepiece respirators against 4 to 30 nanometer-size nanoparticles. Journal of 17 Occupational and Environmental Hygiene 5(9):556-564, which is hereby incorporated by 18 reference).
19 To determine the filtration efficiency of the facemasks of the present invention, we used an NaCl penetration test. In the NaCl penetration test, an aerosol containing 0.3 micron NaCl 21 particles is flowed through the mask at a flow rate of 85 L/min. The testing was performed per 22 NIOSH Procedure # RCT-APR-STP-0057, 0058, and 0059. The TSI Automated Filter Tester 23 8130 was used to generate the data.
24 Two series up masks were tested. One series of masks are characterized as small/medium (S/M). The S/M masks have dimensions of 15.8 x 8.5 cm. The S/M
masks have 26 a meltblown polypropylene filter body 11 with 0.19 mm thickness, a triboelectric polypropylene 27 compressible gasket 12 with 2.69 mm thickness, a polypropylene outer cover scrim 15 with 0.16 28 mm thickness, and a thermal bond polypropylene face side cover scrim 16 with 0.10 mm 29 thickness.
The other series of masks are characterized as medium/large (M/L). The M/L
masks 31 have dimensions of 17 cm x 9.5 cm. The M/L masks have a meltblown polypropylene filter body 22115965.1 15 Agent Ref: 69308/00006 11 with 0.13 mm thickness, a triboelectric polypropylene compressible gasket 12 with 2.69 mm 2 thickness, a polypropylene outer cover scrim 15 with 0.19 mm thickness, and a thermal bond 3 polypropylene face side cover scrim 16 with 0.10 mm thickness.
4 Twenty individual masks from each series were tested. The results from the S/M series are shown in are shown in Table 1 and the results from the M/L series are shown in Table 2.
7 Table 1: Measure of Filtration Efficiency of the S/M Series of Inventive Facemasks NaCl penetration Sample At 851/min (5.00 % max) 1 0.960 2 1.32 3 1.21 4 0.702 5 1.38 6 2.02 7 1.14 8 1.38 9 0.851 1.15 11 2.43 12 1.42 13 2.23 14 2.25 2.52 16 1.59 17 1.22 18 2.33 19 2.70 1.69 Mean 1.62 Std Dev 0.605 22115965.1 16 Agent Ref: 69308/00006 Table 2: Measure of Filtration Efficiency of the M/L Series of Inventive Facemasks NaCl penetration Sample At 85 I/min (5.00 % max) 1 0.281 2 0.529 3 0.999 4 0.498 0.459 6 0.466 7 0.536 8 0.873 9 0.578 0.462 11 0.641 12 0.392 13 0.886 14 0.285 0.143 16 0.469 17 0.202 18 0.289 19 0.273 0.310 Mean 0.479 Std Dev 0.231 3 As shown in Table 1 for the S/M series of facemasks, on average, less than 2.0% of the 4 NaCl particles penetrated the facemasks. As shown in Table 2 for the M/L
series, less than 5 1.0% of the NaCl particles penetrated the facemasks. Hence, the inventive masks demonstrate 6 the filtration performance of at least N95 respirators, where a maximum of 5.0% of NaCl 7 penetration is permitted.
22115965.1 17 Agent Ref: 69308/00006 1 Inhalation and Exhalation Resistance 2 Tests were also conducted to determine inhalation and exhalation resistance of the 3 inventive facemasks. The tests performed were based on ASTM F2100 - Standard 4 Specification For Performance of Materials Used In Medical face Masks. A
value of 35 mm H2O (pressure) or greater indicates that resistance to inhalation is not acceptable. A value of 25 6 mm H2O (pressure) or greater indicates that resistance to exhalation is not acceptable. Results 7 of inhalation and exhalation resistance testing for the S/M series of facemasks of the present 8 invention are shown in Table 3. Results of inhalation and exhalation resistance testing for the 9 M/L series of facemasks of the present invention are shown in Table 4.
Table 3: Measure of Inhalation and Exhalation Resistance of the S/M Series of Inventive 11 facemasks Initial Inhalation Initial Exhalation Sample resistance at 85 Umin resistance at 85 Umin (mm water column) (mm water column) 1 8.5 8.4 2 9.0 8.8 3 8.9 8.7 4 9.6 9.4 5 10.0 9.8 6 8.6 8.4 7 8.8 8 8.3 9 9.8
10 8.6
11 8.9
12 8.7
13 10.1
14 9.1 9.5 16 8.6 17 8.6 18 9.5 19 8.8 8.9 Mean 9.0 8.9 Std Dev 0.527 0.567 22115965.1 18 Agent Ref: 69308/00006 1 Table 4: Measure of Inhalation and Exhalation Resistance of the M/L Series of Inventive 2 facemasks Initial Inhalation Initial Exhalation Sample resistance at 85 Umin resistance at 85 Umin (mm water column) (mm water column) 1 8.8 8.5 2 7.9 7.7 3 8.3 7.8 4 7.7 7.5 8.3 7.9 6 8.1 8.0 7 8.0 8 8.3 9 7.9 8.4 11 8.1 12 7.8 13 8.1 14 8.4 9.3 16 8.1 17 8.8 18 8.6 19 8.5 8.3 Mean 8.3 7.9 Std Dev 0.385 0.341 4 As shown in Table 3 and 4, the mean initial inhalation resistance for the S/M series of 5 inventive facemasks is 9.0 mm H2O and the mean initial exhalation resistance is 8.9 mm H20-6 For the M/L series of inventive facemasks, the mean initial inhalation resistance is 8.3 mm H2O
7 and the mean initial exhalation resistance is 7.9 mm H20. Notably, these values fall well below 8 the acceptable maximum. Hence, the inventive masks not only provide a very high level of 9 filtration efficiency but are easy to breathe through.
10 Sub-micron Particulate, Bacterial, and Viral Filtration Efficiency 11 In addition to the NaCl testing above, the aforementioned inventive facemasks were 12 tested for sub-micron particulate filtration efficiency, bacterial filtration efficiency, and viral 13 filtration efficiency, with results shown in Table 5.
22115965.1 19 Agent Ref: 69308/00006 1 Table 5: Measure of Sub-micron Particulate, Bacterial, and Viral Filtration Efficiencies of 2 Inventive facemasks Test/Standard Challenge Used Results Specification Requirements NIOSH N-Series Filters/ 42 0.3 micron NaCl 98.8% ? 95%
CFR Part 84 particles (NIOSH N95 Rating) Sub-micron Particulate 0.1 micron Latex 99.88% 98%
Filtration Efficiency/ spheres Bacterial Filtration Efficiency Staphylococcus > 99.9% 98%
(BFE)/ASTM F2101 aureus Viral Filtration Efficiency PhiX 174 > 99.9% --(VFE)/ASTM F2101 Modified 4 The sub-micron particulate filtration efficiency of the masks is greater than 99.8% using 0.1 micron Latex spheres according to the ASTM F1215 test procedure.
Furthermore, the 6 bacterial filtration efficiency (BFE) of the masks is greater than 99.9%
using the Staphylococcus 7 aureus challenge according to the ASTM F21 01 test procedure. Moreover, the viral filtration 8 efficiency (VFE) of the masks is greater than 99.9% using the PhiX 174 challenge according to 9 the ASTM F2101 Modified test procedure. Test methods are based on ASTM
F2100, Standard Specification for Performance of Materials Used in Medical Face Masks.
11 These results show that the masks not only meet but clearly exceed NIOSH
N95 rating 12 requirements for filtration of sub-micron particulate, bacteria, and viruses.
13 Antimicrobial Properties of Triosyn-coated Spunbond Polypropylene Outer Scrim 14 Testing was performed to demonstrate the biocidal properties of the above-described spunbond polypropylene outer cover scrim 15 of the inventive facemasks upon coating with 16 iodinated resin.
17 For purposes of the tests, 1 inch x 1 inch pieces of the outer cover scrim material were 18 coated with Triosyn T-50 iodinated resin powder such that the surface concentration of 22115965.1 20 Agent Ref: 69308/00006 1 iodinated resin was 2 g/m2. The water-based adhesive, Simalfa (e.g., made from acrylates 2 copolymer and rubber latex), was used at a concentration of about 4 g/m2.
The Triosyn-treated 3 samples were compared against non-treated 1 inch x 1 inch samples of the scrim material.
4 Both treated and non-treated samples were exposed to 100pL liquid microbial suspension for a
7 and the mean initial exhalation resistance is 7.9 mm H20. Notably, these values fall well below 8 the acceptable maximum. Hence, the inventive masks not only provide a very high level of 9 filtration efficiency but are easy to breathe through.
10 Sub-micron Particulate, Bacterial, and Viral Filtration Efficiency 11 In addition to the NaCl testing above, the aforementioned inventive facemasks were 12 tested for sub-micron particulate filtration efficiency, bacterial filtration efficiency, and viral 13 filtration efficiency, with results shown in Table 5.
22115965.1 19 Agent Ref: 69308/00006 1 Table 5: Measure of Sub-micron Particulate, Bacterial, and Viral Filtration Efficiencies of 2 Inventive facemasks Test/Standard Challenge Used Results Specification Requirements NIOSH N-Series Filters/ 42 0.3 micron NaCl 98.8% ? 95%
CFR Part 84 particles (NIOSH N95 Rating) Sub-micron Particulate 0.1 micron Latex 99.88% 98%
Filtration Efficiency/ spheres Bacterial Filtration Efficiency Staphylococcus > 99.9% 98%
(BFE)/ASTM F2101 aureus Viral Filtration Efficiency PhiX 174 > 99.9% --(VFE)/ASTM F2101 Modified 4 The sub-micron particulate filtration efficiency of the masks is greater than 99.8% using 0.1 micron Latex spheres according to the ASTM F1215 test procedure.
Furthermore, the 6 bacterial filtration efficiency (BFE) of the masks is greater than 99.9%
using the Staphylococcus 7 aureus challenge according to the ASTM F21 01 test procedure. Moreover, the viral filtration 8 efficiency (VFE) of the masks is greater than 99.9% using the PhiX 174 challenge according to 9 the ASTM F2101 Modified test procedure. Test methods are based on ASTM
F2100, Standard Specification for Performance of Materials Used in Medical Face Masks.
11 These results show that the masks not only meet but clearly exceed NIOSH
N95 rating 12 requirements for filtration of sub-micron particulate, bacteria, and viruses.
13 Antimicrobial Properties of Triosyn-coated Spunbond Polypropylene Outer Scrim 14 Testing was performed to demonstrate the biocidal properties of the above-described spunbond polypropylene outer cover scrim 15 of the inventive facemasks upon coating with 16 iodinated resin.
17 For purposes of the tests, 1 inch x 1 inch pieces of the outer cover scrim material were 18 coated with Triosyn T-50 iodinated resin powder such that the surface concentration of 22115965.1 20 Agent Ref: 69308/00006 1 iodinated resin was 2 g/m2. The water-based adhesive, Simalfa (e.g., made from acrylates 2 copolymer and rubber latex), was used at a concentration of about 4 g/m2.
The Triosyn-treated 3 samples were compared against non-treated 1 inch x 1 inch samples of the scrim material.
4 Both treated and non-treated samples were exposed to 100pL liquid microbial suspension for a
15 minute contact time, then the samples were placed in neutralizing fluid to recover viable 6 microorganisms. The viable microorganisms were then counted (CFU). Test methods used 7 were (i) the AATCC Test Method 100-2004: Assessment of Antibacterial Finishes on Textile 8 Materials; and (ii) Protocol No. PRT-M-0035: Surface Antimicrobial Activity Protocol: liquid 9 Innoculum with cover slip.
The test results are shown in Tables 6 - 11 below.
11 Table 6: Antimicrobial Activity of Triosyn-coated Spunbond Polypropylene Outer Scrim -12 Staphylococcus aureus MRSA Test Blank Control Triosyn-coated Contact Time (CFU Total) (% Reduction) 0 min 1.73E+06 N/A
min 1.47E+06 > 99%
13 Detection level = 50 CFU
14 Samples tested n=9
The test results are shown in Tables 6 - 11 below.
11 Table 6: Antimicrobial Activity of Triosyn-coated Spunbond Polypropylene Outer Scrim -12 Staphylococcus aureus MRSA Test Blank Control Triosyn-coated Contact Time (CFU Total) (% Reduction) 0 min 1.73E+06 N/A
min 1.47E+06 > 99%
13 Detection level = 50 CFU
14 Samples tested n=9
16
17 Table 7: Antimicrobial Activity of Triosyn-coated Spunbond Polypropylene Outer Scrim -
18 Vancomycin-Resistant Enterococcus faecalis (VRE) Blank Control Triosyn-coated Contact Time (CFU Total) (% Reduction) 0 min 1.62E+06 N/A
15 min 1.83E+06 > 99%
15 min 1.83E+06 > 99%
19 Detection level = 50 CFU
Samples tested n=9 22115965.1 21 Agent Ref: 69308/00006 1 Table 8: Antimicrobial Activity of Triosyn-coated Spunbond Polypropylene Outer Scrim -2 Escherichia coli Blank Control Triosyn-coated Contact Time (CFU Total) (% Reduction) 0 min 5.47E+06 N/A
15 min 6.40E+06 > 99%
3 Detection level = 50 CFU
4 Samples tested n=9 6 Table 9: Antimicrobial Activity of Triosyn-coated Spunbond Polypropylene Outer Scrim -7 Klebsiella pneumoniae Blank Control Triosyn-coated Contact Time (CFU Total) (% Reduction) 0 min 5.72E+06 N/A
min 5.12E+06 > 99%
8 Detection level = 50 CFU
9 Samples tested n=9 11 Table 10: Antimicrobial Activity of Triosyn-coated Spunbond Polypropylene Outer Scrim 12 - Influenza A H1 N1 Blank Control Triosyn-coated Contact Time (PFU Total) (% Reduction) 0 min 3.38E+06 N/A
min 1.38E+06 > 99%
13 Detection level = 5.56 PFU
14 Samples tested n=18 22115965.1 22 Agent Ref: 69308/00006 2 Table 11: Antimicrobial Activity of Triosyn-coated Spunbond Polypropylene Outer Scrim 3 - Bacteriophage MS2 Coliphage Blank Control Triosyn-coated Contact Time (CFU Total) (% Reduction) 0 min 1.95E+06 N/A
15 min 1.33E+06 > 99%
4 Detection level = 50 CFR
Samples tested n=9 7 Thus, the iodinated-resin-coated, spunbond polypropylene outer cover scrim 15 of the 8 inventive facemasks demonstrate a reduction of each of the following by at least 99% after a 9 contact time of 15 minutes: Staphylococcus aureus MRSA, Vancomycin-Resistant Enterococcus faecalis (VRE), Escherichia coli, Klebsiella pneumoniae, Influenza A H1 N1, and 11 Bacteriophage MS2 Coliphage.
12 While the invention has been particularly shown and described with reference to specific 13 preferred embodiments, it should be understood by those skilled in the art that various changes 14 in form and detail may be made therein without departing from the spirit and scope of the invention as defined by the appended claims. Insofar as this is a provisional application, what is 16 considered applicants' invention is not necessarily limited to embodiments that fall within the 17 scope of the claims below.
22115965.1 23
Samples tested n=9 22115965.1 21 Agent Ref: 69308/00006 1 Table 8: Antimicrobial Activity of Triosyn-coated Spunbond Polypropylene Outer Scrim -2 Escherichia coli Blank Control Triosyn-coated Contact Time (CFU Total) (% Reduction) 0 min 5.47E+06 N/A
15 min 6.40E+06 > 99%
3 Detection level = 50 CFU
4 Samples tested n=9 6 Table 9: Antimicrobial Activity of Triosyn-coated Spunbond Polypropylene Outer Scrim -7 Klebsiella pneumoniae Blank Control Triosyn-coated Contact Time (CFU Total) (% Reduction) 0 min 5.72E+06 N/A
min 5.12E+06 > 99%
8 Detection level = 50 CFU
9 Samples tested n=9 11 Table 10: Antimicrobial Activity of Triosyn-coated Spunbond Polypropylene Outer Scrim 12 - Influenza A H1 N1 Blank Control Triosyn-coated Contact Time (PFU Total) (% Reduction) 0 min 3.38E+06 N/A
min 1.38E+06 > 99%
13 Detection level = 5.56 PFU
14 Samples tested n=18 22115965.1 22 Agent Ref: 69308/00006 2 Table 11: Antimicrobial Activity of Triosyn-coated Spunbond Polypropylene Outer Scrim 3 - Bacteriophage MS2 Coliphage Blank Control Triosyn-coated Contact Time (CFU Total) (% Reduction) 0 min 1.95E+06 N/A
15 min 1.33E+06 > 99%
4 Detection level = 50 CFR
Samples tested n=9 7 Thus, the iodinated-resin-coated, spunbond polypropylene outer cover scrim 15 of the 8 inventive facemasks demonstrate a reduction of each of the following by at least 99% after a 9 contact time of 15 minutes: Staphylococcus aureus MRSA, Vancomycin-Resistant Enterococcus faecalis (VRE), Escherichia coli, Klebsiella pneumoniae, Influenza A H1 N1, and 11 Bacteriophage MS2 Coliphage.
12 While the invention has been particularly shown and described with reference to specific 13 preferred embodiments, it should be understood by those skilled in the art that various changes 14 in form and detail may be made therein without departing from the spirit and scope of the invention as defined by the appended claims. Insofar as this is a provisional application, what is 16 considered applicants' invention is not necessarily limited to embodiments that fall within the 17 scope of the claims below.
22115965.1 23
Claims (30)
1. A protective mask for filtering and/or deactivating contaminants in air, the mask comprising:
a filter body comprising a nonwoven filtering substrate, the filter body configured to cover the mouth and nose of a user when the mask is worn; and a compressible gasket comprising a high loft, porous dielectric filtering material, the gasket positioned along a periphery of the mask, the gasket configured to abut the user's face when the mask is worn, thereby forming a breathable closure without forming an airtight or substantially airtight seal, such that the user can draw breathable air from the sides, top, and bottom of the mask when the mask is worn.
a filter body comprising a nonwoven filtering substrate, the filter body configured to cover the mouth and nose of a user when the mask is worn; and a compressible gasket comprising a high loft, porous dielectric filtering material, the gasket positioned along a periphery of the mask, the gasket configured to abut the user's face when the mask is worn, thereby forming a breathable closure without forming an airtight or substantially airtight seal, such that the user can draw breathable air from the sides, top, and bottom of the mask when the mask is worn.
2. The mask of claim 1, further comprising an outer cover scrim comprising an active agent, the outer cover scrim forming the outermost layer of the mask and configured to be exposed to the user's environment when the mask is worn.
3. The mask of claim 2, wherein the active agent comprises a biocidal iodinated resin.
4. The mask of claim 1, wherein the mask comprises a plurality of stacked layers and the filter body and compressible gasket have substantially equivalent outer dimensions and are two of the stacked layers of the mask.
5. The mask of claim 2, wherein the outer cover scrim is coated with the active agent on at least a portion of its outer facing side, and the active agent prevents surface contamination.
6. The mask of claim 2, wherein the active agent is embedded within a matrix of the outer cover scrim and/or is incorporated in fibers of the outer cover scrim.
7. The mask of claim 2, further comprising a face side cover scrim, wherein the filter body is surrounded by the outer cover scrim and the face side cover scrim.
8. The mask of claim 7, wherein the outer cover scrim and face side cover scrim are each between about 0.1 and about 0.2 mm in thickness.
9. The mask of claim 7, wherein the outer cover scrim and/or face side cover scrim comprises spunbond media.
10. The mask of claim 1, wherein the filter body comprises a meltblown nonwoven material.
11. The mask of claim 1, wherein the compressible gasket comprises triboelectric media.
12. The mask of claim 11, wherein the compressible gasket comprises at least two different types of fiber which create an inherent charge [no additional charge needs to be applied].
13. The mask of claim 11, wherein the compressible gasket comprises polypropylene fiber and modacrylic fiber.
14. The mask of claim 1, wherein at least one of the filter body and the compressible gasket comprises a biocidal active agent that kills microorganisms filtered from the air.
15. The mask of claim 14, wherein the biocidal active agent comprises iodinated resin.
16. The mask of claim 14, wherein the active agent is embedded in the fiber matrix and/or incorporated in the fibers of at least one of the filter body and the compressible gasket.
17. The mask of claim 1, wherein the compressible gasket is at least about 1.5 mm thick.
18. The mask of claim 1, wherein the compressible gasket is at least about 2.5 mm thick.
19. The mask of claim 1, wherein the compressible gasket has a thickness within a range from about 2 mm to about 5 mm.
20. The mask of claim 1, wherein the filter body has a thickness within a range from about 0.1 mm to about 0.3 mm.
21. The mask of claim 1, wherein the compressible gasket defines an interior opening such that the porous dielectric filtering material of the gasket does not cover the mouth and/or nose of the user when the mask is worn.
22. The mask of claim 21, wherein the compressible gasket has a width measured from the outer edge to the interior opening in a direction perpendicular to the edge of at least 1 cm.
23. The mask of claim 21, wherein the dielectric filtering material of the compressible gasket has a quasi-permanent electric charge.
24. The mask of claim 1, wherein the nonwoven filtering substrate of the filter body has a quasi-permanent electric charge.
25. The mask of claim 1, wherein the mask is a N95 respirator.
26. The mask of claim 1, wherein the mask is a member selected from the group consisting of a respirator, a face shield, a face mask, a surgical mask, a filter mask, a mouth mask, and a gas mask.
27. The mask of claim 1, wherein the mask has initial inhalation resistance at 85 l/min less than 35 mm H2O and initial exhalation resistance at 85 l/min less than 25 mm H2O.
28. The mask of claim 27, wherein the mask has initial inhalation resistance at 85 lpm less than 15 mm H2O and initial exhalation resistance at 85 l/min less than 15 mm H2O.
29. The mask of claim 27, wherein the mask has NaCl penetration at 85 l/min less than 5.0%.
30. The mask of claim 29, wherein the mask has NaCl penetration at 85 l/min less than 3.0%.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35000210P | 2010-05-31 | 2010-05-31 | |
US61/350,002 | 2010-05-31 | ||
US12/792,364 | 2010-06-02 | ||
US12/792,364 US20100313890A1 (en) | 2002-09-16 | 2010-06-02 | Protective mask with breathable filtering face seal |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2741799A1 true CA2741799A1 (en) | 2011-11-30 |
Family
ID=45066027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2741799A Abandoned CA2741799A1 (en) | 2010-05-31 | 2011-05-31 | Protective mask with breathable filtering face seal |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2741799A1 (en) |
-
2011
- 2011-05-31 CA CA2741799A patent/CA2741799A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100313890A1 (en) | Protective mask with breathable filtering face seal | |
JP5155884B2 (en) | Multilayer mask | |
US7744681B2 (en) | Antimicrobial filtration article | |
JP4823314B2 (en) | Bactericidal face mask | |
US10201198B2 (en) | Protective masks with coating comprising different electrospun fibers interweaved with each other, formulations forming the same, and method of producing thereof | |
KR100956032B1 (en) | Microbicidal air filter | |
CN110236248B (en) | Method for reducing microbial inhalation, mask, use thereof and method for manufacturing same | |
US20050079379A1 (en) | Enhancement of barrier fabrics with breathable films and of face masks and filters with novel fluorochemical electret reinforcing treatment | |
US20110114095A1 (en) | Antiviral metal impregnated activated carbon cloth components | |
KR101224786B1 (en) | Antibacterial mask emitting phytoncide | |
JP2011167226A (en) | Antibacterial mask, antibacterial filter for the mask, and antibacterial method using the mask or the filter | |
US11849782B2 (en) | Facemask | |
TW201630994A (en) | Antimicrobial fabric materials for use in safety masks and personal protection clothing | |
JP2011224094A (en) | Filter material for mask and mask | |
Sozkes et al. | COVID-19 and respiratory protection for healthcare providers | |
US20230241427A1 (en) | Improved filtering mask | |
Neupane et al. | Current understanding on the effectiveness of face masks and respirators to prevent the spread of respiratory viruses | |
WO2021229444A1 (en) | Novel and improved biodegradable face mask with inherent virucide, hydrophobic and hydrophillic properties with adjustable ear loops | |
CA2741799A1 (en) | Protective mask with breathable filtering face seal | |
WO2021160178A1 (en) | Protective mask, air filtration element and air treatment element | |
US20220143538A1 (en) | Filtration system and method of use thereof | |
Angelova | Materials, design and technology of face masks | |
EP3991823A1 (en) | Face mask | |
WO2022195498A1 (en) | Filtering means of a wearable face mask | |
WO2022195506A1 (en) | Face mask configured to filter air |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |
Effective date: 20140602 |